Chemed Corporation
CHE
$439.19
-$2.17-0.49%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.45% | 7.55% | 8.52% | 7.37% | 6.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.45% | 7.55% | 8.52% | 7.37% | 6.83% |
| Cost of Revenue | 11.06% | 11.44% | 9.62% | 7.60% | 4.98% |
| Gross Profit | -1.85% | 0.62% | 6.54% | 6.95% | 10.34% |
| SG&A Expenses | 0.18% | -0.17% | 2.10% | 6.05% | 6.03% |
| Depreciation & Amortization | 2.53% | 2.19% | 2.24% | 3.59% | 4.71% |
| Other Operating Expenses | 96.45% | 96.73% | 97.51% | -- | -168.47% |
| Total Operating Expenses | 8.63% | 8.80% | 7.91% | 7.15% | 4.95% |
| Operating Income | -5.30% | 0.83% | 11.99% | 8.59% | 18.27% |
| Income Before Tax | -6.20% | 0.20% | 12.91% | 14.01% | 24.52% |
| Income Tax Expenses | -1.67% | 13.15% | 26.95% | 25.18% | 28.39% |
| Earnings from Continuing Operations | -7.60% | -3.51% | 8.94% | 10.82% | 23.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.60% | -3.51% | 8.94% | 10.82% | 23.37% |
| EBIT | -5.30% | 0.83% | 11.99% | 8.59% | 18.27% |
| EBITDA | -4.17% | 1.08% | 10.68% | 7.97% | 16.61% |
| EPS Basic | -4.77% | -1.52% | 10.36% | 11.17% | 22.72% |
| Normalized Basic EPS | -5.04% | 0.43% | 12.18% | 15.28% | 24.77% |
| EPS Diluted | -4.42% | -1.34% | 10.52% | 11.14% | 22.61% |
| Normalized Diluted EPS | -4.66% | 0.61% | 12.34% | 15.20% | 24.54% |
| Average Basic Shares Outstanding | -3.12% | -2.15% | -1.25% | -0.17% | 0.55% |
| Average Diluted Shares Outstanding | -3.54% | -2.35% | -1.40% | -0.08% | 0.74% |
| Dividend Per Share | 23.53% | 25.00% | 20.25% | 15.38% | 10.39% |
| Payout Ratio | 0.30% | 0.26% | 0.09% | 0.04% | -0.10% |